Illumina is a global company that develops innovative array-based solutions for DNA, RNA, and protein analysis. By empowering the genetic analysis research of our customers, our tools make a difference in disease research, drug development, and the development of molecular tests in the clinic.
Location: United States
Employees: 5001-10000
Phone: +1 858-202-4500
Total raised: $1.01B
Founded date: 1998
Investors 2
| Date | Name | Website |
| - | Plug and P... | plugandpla... |
| - | RONA Holdi... | ronaholdin... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 06.01.2017 | Series B | $1B | - |
| 06.06.2007 | - | $7M | - |
Mentions in press and media 17
| Date | Title | Description |
| 15.04.2025 | Illumina and Tempus Partner to Drive the Future of Precision Medicine Through Genomic AI Innovation | Illumina a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation. ... |
| 08.02.2021 | LifeArc invests £10 million in Illumina Accelerator to Advance Genomics Startups | London, February 8, 2021: LifeArc announced today a £10 million cornerstone investment in the funding cycle of Illumina Accelerator Cambridge. This is part of over £20 million in initial UK capital commitments Illumina has secured from a se... |
| 25.05.2018 | Illumina Spinout Grail Gets $300M More For Cancer Detection Testing | Grail, the spinout of San Diego-based life sciences equipment maker Illumina, has raised $300M more in funding, the company said this week. The startup is developing blood testing technology which uses DNA analysis to help in early detectio... |
| 17.10.2017 | Illumina Ventures Raises $230M Venture Capital Fund | Illumina Ventures, the early-stage venture capital investor which was founded by San Diego-based life sciences equipment maker Illumina, says it has raised $230M for its first fund. The venture capital investment fund said it is focused on ... |
| 06.01.2017 | Illumina Spinout Plans To Raise $1 Billion In Series B | San Diego-based life sciences equipment maker Illumina says that its cancer detection spinout, GRAIL, is now expecting to raise approximately $1 billion in its Series B funding. GRAIL, which was founded by Illumina, is developing blood test... |
| 15.04.2016 | Illumina Launches $100M Venture Capital Fund | San Diego, CA-based DNA sequencing company Illumina, Inc., (NASDAQ: ILMN) has committed to invest $100M in a new venture capital firm that is strategically aligned with its vision to improve human health by leveraging the genome potential. ... |
| 13.10.2015 | High-res microscopy startup backed by Illumina cofounder gets $5.15M | Ultivue’s reagent kits take advantage of the dynamic and tunable properties of interacting short DNA strands. DNA strands are used to guide and transiently label target biomolecules to reveal exquisite spatial resolution and quantitative in... |
| 27.02.2015 | Illumina Accelerator Boost Capital Raises $40M from Viking Global Investors | Sequencing and array-based technology developer Illumina has announced that (NASDAQ:ILMN)’s new Illumina Accelerator Boost Capital has secured an initial capital commitment of $40m from global investment firm Viking Global Investors. The ca... |
| 15.11.2012 | The $1,000 genome question has turned into, “How can we understand this data?” | Life Technologies and Harvard Medical School professor George Church may be the only ones who have officially thrown their hats in the ring for the $10 million Archon Genomics X Prize, but many others have made ambitious promises in the que... |
| 30.04.2008 | NextBio semantic search promises new opportunities for health researchers | The Internet long ago shed its ethereal status as a meeting ground for researchers and scientists, but that doesn’t mean it has lost its utility for those groups. New technologies, now mainly aimed at general consumer applications, are also... |
Show more